CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 15 enrolled
Drug / intervention
InDx Implant for the carpometacarpal jointdevice
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT05644132
NCT05644132N/ACompleted
CompareCT.gov

Thumb Hemi-Arthroplasty With Natural Kinematics (THANKS) Trial

Loci Orthopaedics·interventional·Posted Dec 9, 2022·Updated Aug 26, 2024

In Brief

A clinical study evaluating InDx Implant for the carpometacarpal joint for Osteoarthritis Thumb Base Joint. Completed, enrolled 15 participants across 1 site.

Detailed Summary

This clinical trial aims to evaluate the safety and effectiveness of the lnDx Implant in the treatment of thumb base joint arthritis. This clinical trial hypothesises that implanting the lnDx prosthesis will improve thumb opposition motion, decrease pain and stiffness, and increase grip and pinch strengths of the carpometacarpal joint in patients with thumb base joint arthritis. Participants will undergo the following measures to assess their clinical performance: * Hand X-Ray * Range of Motion - Kapandji opposition score * Grip strength, lateral pinch and tip pinch * Visual Analogue Scale (VAS) for Pain * Quick Disabilities of the Arm, Shoulder, and Hand (DASH) questionnaire

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsOsteoarthritis Thumb Base Joint
CountriesBelgium
CollaboratorsNorth American Science Associates Ltd.

Timeline

N/ACompletedFinished
20222023202420252026
First PostedDec 9, 2022
Enrollment StartAug 6, 2021
Primary CompletionJun 4, 2024
TodayJul 2, 2026
Enrollment to primary: 2.8 yearsPosted 3.6 years ago

Interventions

InDx Implant for the carpometacarpal jointdevice

Treatment of thumb base joint arthritis with the InDx Implant